The House Judiciary Committee revealed Thursday that Pfizer’s former Global Head of Vaccines Research and Development, Dr.

Pfizer beats EPS estimates for the 12th quarter. Explore PFE's oncology success, cost-cutting impact, and why it's rated a ...

On Nov. 9, 2020, Pfizer and partner BioNTech announced that the vaccine had met the first effectiveness bar in a key study.

In today’s CEO Daily: Diane Brady talks to Pfizer CEO Albert Bourla about defending science amid a backdrop of political threats. The big story: Trump’s tariff regime is open to compromises.

For investors willing to look beyond the current negative sentiment, Pfizer at today's prices represents a rare buying ...

U.S. lawmakers have requested information from Pfizer concerning claims by former executive Philip Dormitzer that the company ...

but Pfizer CEO Albert Bourla has said the timing had nothing to do with politics. In an interview with CNN Chief Medical Correspondent Sanjay Gupta in 2020, Bourla threw cold water on the idea ...

US House Panel Seeks Information From Pfizer Over Alleged COVID Vaccine Delay By Ahmed Aboulenein and Michael Erman WASHINGTON (Reuters) -U.S. lawmakers on Thursday asked Pfizer Inc for ...